Elsevier

Blood Cells, Molecules, and Diseases

Volume 31, Issue 3, November–December 2003, Pages 360-369
Blood Cells, Molecules, and Diseases

Regular article
Effects of human locus control region elements HS2 and HS3 on human β-globin gene expression in transgenic mouse

https://doi.org/10.1016/j.bcmd.2003.07.001Get rights and content

Abstract

The locus control region (LCR) is the most important cis-element in the regulation of β-globin gene expression. DNaseI-hypersensitive site (HS) 2 and HS3 are two significant components of β-LCR. To examine the effect of HS2, HS3, and HS2–HS3 (combination of HS2 and HS3) on the spatial and temporal expression of the human β-globin gene, we have produced transgenic mice with constructs, in which the gene encoding enhanced green fluorescent protein (EGFP) is driven by β-globin promoter and under the control of HS2, HS3, and HS2–HS3, respectively. The results showed that HS2 and HS3 each had the same enhancement activity in regulation of β-globin gene expression in transgenic mice. When HS2 and HS3 were in combination (HS2–HS3), the two cis-elements showed a marked synergy in regulating β-globin gene spatial and temporal expression as well as its expression level in transgenic mice although the EGFP expression varied largely among different transgenic mouse litters. The results also showed that HS2 was able to confer β-globin gene expression in embryonic yolk sac, fetal liver, and adult bone marrow, which was not developmentally stage-specific, while HS3 could confer the same β-globin gene expression in the adult. Thus, HS3 was different from HS2, the former being more important for specific expression of β-globin gene in the developmental stages and the switch of γ→β-globin genes. Our results indicate that the mechanism of γ→β switch could be best explained by the “divided model.”

Introduction

Human β-globin gene locus contains five functional genes. They are arranged 5′ε-Gγ-Aγ-ψβ-δ-β-3′ from the centromere to the telomere on chromosome 11 (11p15.5) and they are expressed in erythroid tissues in this order at several developmental stages. ε-Globin gene is expressed embryonically, γ-globin genes are expressed fetally, and β-globin gene is expressed in adults. Thus, there are two developmental stages in β-globin locus expression. One is embryonic-to-fetal (ε→γ) switch, and the other is fetal-to-adult (γ→β) switch. The mechanisms underlying these two switching processes offer solid insight into the study of the regulation of eukaryotic gene expression.

The expression of human β-globin locus is under the control of the coregulation of proximal elements (such as promoters, enhancers) and distal elements (known as locus control region, LCR) [1], [2], [3], [4], [5]. LCR is the most important cis-element for the regulation of β-globin locus expression. LCR is located 5 to 22-kilobases (kb) upstream of ε-globin and consists of five DNaseI-hypersensitive sites (HS1–5) [6], [7]. LCR controls the chromatin structure, transcription, and replication properties of β-globin locus [8], [9], [10], [11], [12]. LCR is required for domain-opening, enhancement of β-like globin gene expression, and insulation from position effects [13], [14], [15].

Individual HSs have a core fragment of 200–400 bp, which is conserved and required for their functions. However, the flanking sequences of individual HSs are also required for their functions and interaction among them [13], [16], [17]. HS1 has no appreciable activity in most transfection assays and transgenic mice [18], [19]. Human HS5 may have some function as an insulator [20]. But in the erythroid background, the deletion of HS5 has only a small effect on transcription of the β-globin genes and no effect on the formation of neighboring HSs [11]. HS4 has a stronger effect in transgenic mice than in stably or transiently transfected cells, and can contribute an increased expression in combination with other HSs [21], [22]. HS2 can enhance expression of β-like globin gene both transiently from integrated constructs and after integration into a chromosome in transfected erythroid cell lines [22], [23]. HS2 will confer position independent and high-level expression in transgenic mice [24]. In addition, HS2 may confer some β-like globin gene developmental stage-specific expression [25]. HS3 has weak or no enhancer activity in transiently transfected cells. However, HS3 has the activity of enhancement and chromatin domain opening when stably integrated into chromosome in transfected cells or transgenic mice [26], [27]. These results show that HS2 and HS3 are two significant components of β-LCR. However, it is not yet clear how these HSs elements act in regulating spatial and temporal expression of β-like globin genes, how their activities lead to the full activity of LCR, and how these individual HSs interact.

In order to examine the effect of human LCR elements HS2, HS3, and HS2–HS3 (combination of HS2 and HS3) on human β-globin gene spatial and temporal expression, three erythroid-specific recombinant plasmids were constructed and their expressions in transgenic mice were measured. We found that HS2 and HS3 in combination showed a marked synergy in regulating β-globin gene spatial and temporal expression and its expression level in transgenic mice, and HS3 was more important than HS2 for specific expression of β-globin gene in the developmental stages and the switch of γ→β-globin genes.

Section snippets

Plasmid construction

Plasmid HS2ALL, HS3ALL, and HS23ALL were constructed, so that the reporter gene encoding enhanced green fluorescent protein (EGFP) was driven by the β-globin promoter (1.7 kb to +1 relative to the cap site) and under the control of HS2 (3.2 kb MfeI–MfeI), HS3 (3 kb HpaI–MfeI), and HS2–HS3 (6.2 kb, HpaI–MfeI), respectively. Both HS2 and HS3 contained their cores, flanking, and interspacer sequences. The 1-kb EGFP fragment was removed by digestion with EcoRI and AflII from pEGFP-N1 (Clontech). In

HS2 and HS3 each had the same enhancement activity and in combination showed marked synergy in transcriptional regulation of the transgenic β-promoter-EGFP

EGFP expression in adult transgenic mouse peripheral blood was measured with FACS. The average percentage of EGFP positive blood cells in six HS2/GFP transgenic mice was 1.81% (2, 1.6, 0.6, 1, 1.5, and 4.2%, respectively). The average percentage of EGFP positive blood cells in four HS3/GFP transgenic mice was 1.91% (2.6, 1.1, 0.45, and 3.5%, respectively). And the average percentage of EGFP positive blood cells in three HS2-3/GFP transgenic mice was 46.5% (4.5, 80.1, and 46.4%, respectively).

Discussion

We used transgenic mice with constructs, in which EGFP is driven by β-globin promoter and under the control of HS2, HS3, and HS2–HS3 to investigate the human β-globin gene spatial and temporal expression. Our results showed that a 3.2-kb DNA fragment containing the entire HS2 region could confer β-globin gene expression in embryonic yolk sac, fetal liver, and adult bone marrow, which was not developmental stage-specific. Our results also showed that HS3 could confer β-globin gene expression in

Acknowledgements

This work was supported by the Chinese National Science Foundation (Grant 39893320) and China “863” High Tech Program (Grant 2002AA206211 and 2002AA216091).

References (36)

  • T. Enver et al.

    Analysis of the developmental and transcriptional potentiation functions of 5′ HS2 of the murine beta-globin locus control region in transgenic mice

    Dev Biol.

    (1994)
  • T. Yu et al.

    Regulation of fetal versus embryonic gamma globin genesappropriate developmental stage expression patterns in the presence of HS2 of the locus control region

    Blood

    (2002)
  • J.D. Engel et al.

    Looping, linking, and chromatin activitynew insights into beta-globin locus regulation

    Cell

    (2000)
  • W.C. Forrester et al.

    A developmentally stable chromatin structure in the human beta-globin gene cluster

    Proc. Natl. Acad. Sci. USA

    (1986)
  • W.C. Forrester et al.

    A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus

    Genes Dev.

    (1990)
  • W.C. Forrester et al.

    A developmentally stable chromatin structure in the human β-globin gene cluster

    Proc. Natl. Acad. Sci. USA

    (1986)
  • V. Dhar et al.

    Erythroid-specific nuclease-hypersensitive sites flanking the human beta-globin domain

    Mol. Cell. Biol.

    (1990)
  • R. Alami et al.

    β-globin YAC transgenes exhibit uniform expression levels but position effect variegation in mice

    Hum. Mol. Genet.

    (2000)
  • Cited by (0)

    View full text